Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pharmacoeconomics. 2002;20(5):347-55.

The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden.

Author information

  • 1Family Medicine Stockholm, Karolinska Institute, Sweden. lars.agreus@klinvet.ki.se

Erratum in

  • Pharmacoeconomics. 2003;21(2):148..

Abstract

BACKGROUND AND OBJECTIVE:

Dyspepsia, peptic ulcer disease (PUD) and gastro-oesophageal reflux disease (GORD) involve a substantial cost to Swedish society. There is a lack of up-to-date nationwide cost estimates after 1985. This study was conducted to present a comprehensive and updated cost analysis and study the change over time of the national cost of these disorders.

DESIGN AND SETTING:

Primarily, data from National Swedish databases and secondly, data from databases from the County of Uppsala for 1997 were used for the calculations and estimations.

PERSPECTIVE:

Swedish societal perspective.

RESULTS:

The total cost to Swedish society of dyspepsia, PUD and GORD in 1997 was $US424 million, or $US63 per adult. Direct costs totalled $US258 million (61%) while indirect costs totalled $US166 million (39%). The highest proportions of costs were due to drugs and sick leave, these being 37 and 34%, respectively.

CONCLUSIONS:

The cost of dyspepsia and GORD is substantial for patients, health providers and society. Since 1985, drug costs have increased substantially while the cost of sick leave has decreased.

PMID:
11994044
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk